Cargando…

Montreal Brain Injury Vision Screening Test for General Practitioners

Visual disturbances are amongst the most commonly reported symptoms after a traumatic brain injury (TBI) despite vision testing being uncommon at initial clinical evaluation. TBI patients consistently present a wide range of visual complaints, including photophobia, double vision, blurred vision, an...

Descripción completa

Detalles Bibliográficos
Autores principales: Abbas Farishta, Reza, Farivar, Reza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330036/
https://www.ncbi.nlm.nih.gov/pubmed/35911590
http://dx.doi.org/10.3389/fnhum.2022.858378
_version_ 1784758063703523328
author Abbas Farishta, Reza
Farivar, Reza
author_facet Abbas Farishta, Reza
Farivar, Reza
author_sort Abbas Farishta, Reza
collection PubMed
description Visual disturbances are amongst the most commonly reported symptoms after a traumatic brain injury (TBI) despite vision testing being uncommon at initial clinical evaluation. TBI patients consistently present a wide range of visual complaints, including photophobia, double vision, blurred vision, and loss of vision which can detrimentally affect reading abilities, postural balance, and mobility. In most cases, especially in rural areas, visual disturbances of TBI would have to be diagnosed and assessed by primary care physicians, who lack the specialized training of optometry. Given that TBI patients have a restricted set of visual concerns, an opportunity exists to develop a screening protocol for specialized evaluation by optometrists—one that a primary care physician could comfortably carry out and do so in a short time. Here, we designed a quick screening protocol that assesses the presence of core visual symptoms present post-TBI. The MOBIVIS (Montreal Brain Injury Vision Screening) protocol takes on average 5 min to perform and is composed of only “high-yield” tests that could be performed in the context of a primary care practice and questions most likely to reveal symptoms needing further vision care management. The composition of our proposed protocol and questionnaire are explained and discussed in light of existing protocols. Its potential impact and ability to shape a better collaboration and an integrative approach in the management of mild TBI (mTBI) patients is also discussed.
format Online
Article
Text
id pubmed-9330036
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-93300362022-07-29 Montreal Brain Injury Vision Screening Test for General Practitioners Abbas Farishta, Reza Farivar, Reza Front Hum Neurosci Human Neuroscience Visual disturbances are amongst the most commonly reported symptoms after a traumatic brain injury (TBI) despite vision testing being uncommon at initial clinical evaluation. TBI patients consistently present a wide range of visual complaints, including photophobia, double vision, blurred vision, and loss of vision which can detrimentally affect reading abilities, postural balance, and mobility. In most cases, especially in rural areas, visual disturbances of TBI would have to be diagnosed and assessed by primary care physicians, who lack the specialized training of optometry. Given that TBI patients have a restricted set of visual concerns, an opportunity exists to develop a screening protocol for specialized evaluation by optometrists—one that a primary care physician could comfortably carry out and do so in a short time. Here, we designed a quick screening protocol that assesses the presence of core visual symptoms present post-TBI. The MOBIVIS (Montreal Brain Injury Vision Screening) protocol takes on average 5 min to perform and is composed of only “high-yield” tests that could be performed in the context of a primary care practice and questions most likely to reveal symptoms needing further vision care management. The composition of our proposed protocol and questionnaire are explained and discussed in light of existing protocols. Its potential impact and ability to shape a better collaboration and an integrative approach in the management of mild TBI (mTBI) patients is also discussed. Frontiers Media S.A. 2022-07-14 /pmc/articles/PMC9330036/ /pubmed/35911590 http://dx.doi.org/10.3389/fnhum.2022.858378 Text en Copyright © 2022 Abbas Farishta and Farivar. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Human Neuroscience
Abbas Farishta, Reza
Farivar, Reza
Montreal Brain Injury Vision Screening Test for General Practitioners
title Montreal Brain Injury Vision Screening Test for General Practitioners
title_full Montreal Brain Injury Vision Screening Test for General Practitioners
title_fullStr Montreal Brain Injury Vision Screening Test for General Practitioners
title_full_unstemmed Montreal Brain Injury Vision Screening Test for General Practitioners
title_short Montreal Brain Injury Vision Screening Test for General Practitioners
title_sort montreal brain injury vision screening test for general practitioners
topic Human Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330036/
https://www.ncbi.nlm.nih.gov/pubmed/35911590
http://dx.doi.org/10.3389/fnhum.2022.858378
work_keys_str_mv AT abbasfarishtareza montrealbraininjuryvisionscreeningtestforgeneralpractitioners
AT farivarreza montrealbraininjuryvisionscreeningtestforgeneralpractitioners